Has that been ever explained?
If production speed was a concern, then why not take orders like other successful companies do when they release a new product?
Why in the world SANOFI would ever back away from Afrezza?
Would it be because slow production by MNKD or competition with Sanofi's it's own insulin?
It's hard to tell.
Stop saying they are trapped!
The only ones trapped are us longs.
If you are under water, them you are trapped and they want you to sell.
Are you selling?
Dealing with Greek situation my expedite a BO.
Al Mann is not one for accounting details and Greek situation may require complex creative accounting.
This needs to be bumped non-stop ... everyone is waiting for this ... longs and shorts.
Keep up the good research.
Nope ... you got it all wrong.
First hop $15
Second hop $25
Third hop $50.
Will you be still shorting then?
Every mentioned thought is 101% accurate.
It's the pharmaceuticals protecting their turf.
I just hope SNY is not among them with this ridiculous soft launch.
Everyone I mention Afrezza to are excited about this new drug. They all ask if it's available yet. All are excited about replacing the needles, refrigeration and privacy. Afrezza only needs to be advertised and we are almost there.
I wonder what this does to the morale of rest of the crew?